Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02660554 · ClinicalTrials.gov registry record · NA
Trial of MRSA Polymerase Chain Reaction for Pneumonia
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT02660554: Completed NA study, sponsored by Northwestern University.
NCT02660554 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02660554, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to conduct a randomized clinical trial to compare an antibiotic strategy based on a novel diagnostic test, polymerase chain reaction (PCR) to usual care, in critically ill adults with pneumonia suspected to be caused by methicillin resistant staphylococcus aureus (MRSA). The investigators hypothesize that when automated PCR is used to guide antibiotic therapy, antibiotic exposure will be reduced in critically ill subjects with pneumonia.
Primary Outcome
days for initially suspected MRSA pneumonia
Interventions
- OTHER Polymerase Chain Reaction (PCR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-01 |
| Est. Completion | 2019-05-03 |
| Phase | NA |
What the finished NCT02660554 record still lists
NCT02660554 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Polymerase Chain Reaction (PCR) is the first listed.
NCT02660554 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02660554 about?
NCT02660554 is a clinical study titled "Trial of MRSA Polymerase Chain Reaction for Pneumonia". The purpose of this study is to conduct a randomized clinical trial to compare an antibiotic strategy based on a novel diagnostic test, polymerase chain reaction (PCR) to usual care, in critically ill adults with pneumonia suspected to be caused by methicillin resistant staphylococcus aureus (MRSA)....
What is the current status of trial NCT02660554?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2016-01. Estimated completion is 2019-05-03.
What interventions are being tested in trial NCT02660554?
The interventions under investigation include: Polymerase Chain Reaction (PCR) (OTHER).
Who is sponsoring clinical trial NCT02660554?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02660554's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia